Deutsche Bank Aktiengesellschaft »

Galectin Therapeutics shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2026-06-30 $220k 47k 4.64
2021-03-31 $59k 25k 2.33
2020-12-31 $65k 28k 2.33
2020-09-30 $47k 20k 2.33
2020-06-30 $57k 18k 3.11
2020-03-31 $28k 14k 1.99
2019-12-31 $50k 21k 2.33
2019-09-30 $37k 12k 3.11
2019-06-30 $0 30k 0.00
2019-03-31 $309k 61k 5.09
2018-09-30 $0 2 0.00
2018-06-30 $8.0k 1.3k 6.15
2018-03-31 $12k 2.6k 4.62
2017-12-31 $0 2 0.00
2017-09-30 $0 2 0.00
2017-06-30 $0 102 0.00
2017-03-31 $0 2 0.00
2016-12-31 $0 2 0.00
2016-09-30 $0 2 0.00
2016-06-30 $0 13 0.00
2016-03-31 $2.0k 1.5k 1.33
2015-12-31 $7.3k 5.5k 1.33
2015-09-30 $3.0k 1.5k 2.00
2015-06-30 $9.1k 3.5k 2.63
2015-03-31 $8.0k 2.6k 3.09
2014-12-31 $104k 32k 3.31
2014-09-30 $152k 32k 4.78
2014-06-30 $418k 32k 13.23
2014-03-31 $48k 3.1k 15.26